ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC13473-100mg |
|
847871-99-2 |
Lenalidomide hemihydrate
|
0 | C26H28N6O7 | |
GC13473-50mg |
|
847871-99-2 |
Lenalidomide hemihydrate
|
0 | C26H28N6O7 | |
GC13472-5mg |
|
65144-34-5 |
Elastase Inhibitor, SPCK
|
0 | C22H35ClN4O7 | |
GC13471-10mg |
|
1350622-33-1 |
kb-NB77-78
|
0 | C18H25NO3Si | |
GC13471-5mg |
|
1350622-33-1 |
kb-NB77-78
|
0 | C18H25NO3Si | |
GC13470-5mg |
|
500-65-2 |
Rhapontigenin
|
0 | C15H14O4 | |
GC13470-20mg |
|
500-65-2 |
Rhapontigenin
|
0 | C15H14O4 | |
GC13470-10mg |
|
500-65-2 |
Rhapontigenin
|
0 | C15H14O4 | |
GC13469-50mg |
|
7491-74-9 |
Piracetam
|
0 | C6H10N2O2 | |
GC13468-10mM (in 1mL DMSO) |
|
501437-28-1 |
BI-D1870
|
0 | C19H23F2N5O2 | |
GC13468-50mg |
|
501437-28-1 |
BI-D1870
|
0 | C19H23F2N5O2 | |
GC13468-10mg |
|
501437-28-1 |
BI-D1870
|
0 | C19H23F2N5O2 | |
GC13468-5mg |
|
501437-28-1 |
BI-D1870
|
0 | C19H23F2N5O2 | |
GC13467-50mg |
|
173039-10-6 |
PMPA (NAALADase inhibitor)
|
0 | C6H11O7P | |
GC13467-10mg |
|
173039-10-6 |
PMPA (NAALADase inhibitor)
|
0 | C6H11O7P | |
GC13466-50mg |
|
530-78-9 |
Flufenamic acid
|
0 | C14H10F3NO2 | |
GC13465-1g |
|
14362-31-3 |
Chlorcyclizine (hydrochloride)
|
0 | C18H21ClN2 • HCl | |
GC13465-500mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride)
|
0 | C18H21ClN2 • HCl | |
GC13465-250mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride)
|
0 | C18H21ClN2 • HCl | |
GC13465-100mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride)
|
0 | C18H21ClN2 • HCl | |